Table 1

OGAT activity, MMR efficiency, and sensitivity to TMZ, BCNU, or CDDP of human melanoma cell lines

Cell Line1-aOGAT1-b% MMR1-cIC501-d
TMZTMZ + LTE/BG1-eBCNUBCNU + LTE/BG1-eCDDP
μM
CR-MelN.D.35–3992  ± 16103  ± 1338  ± 5.440  ± 7.44.0  ± 0.6
LCP-Mel-Clone E4N.D.44–46103  ± 14103  ± 8.013  ± 1.112  ± 1.28.5  ± 0.3
PR-Mel12  ± 63–11>1000>100017  ± 1.517  ± 0.67.0  ± 0.9
GL-Mel52  ± 677–88148  ± 1736  ± 6.51-160 47  ± 2.537  ± 3.41-150 8.7  ± 0.9
M14107  ± 2187–93101  ± 1123  ± 3.61-160 82  ± 1055  ± 6.01-150 11  ± 1.2
LCP-Mel184  ± 3337–40218  ± 20143  ± 321-150 13  ± 1.08.2  ± 0.51-160 5.6  ± 0.3
LCP-Mel-Clone E3331  ± 4645–47368  ± 36145  ± 351-160 45  ± 4.49.2  ± 1.31-160 8.3  ± 1.2
M10533  ± 4589–92301  ± 2824  ± 4.01-160 57  ± 5.522  ± 2.41-160 3.3  ± 0.3
PD-Mel631  ± 642–9448  ± 32436  ± 4347  ± 3.522  ± 1.41-160 19  ± 2.5
SK-Mel-28660  ± 2243–49688  ± 47331  ± 131-160 70  ± 2.534  ± 0.31-160 11  ± 0.9
CN-Mel827  ± 7290–94778  ± 32369  ± 131-160 74  ± 2.935  ± 2.11-160 20  ± 4.5
  • N.D., not detectable.

  • 1-a  Cells were incubated with graded concentrations of the indicated drugs for 5 days and then analyzed for cell growth by the MTT assay.

  • 1-b  OGAT activity is expressed in terms of fmoles of 3H-methyl groups transferred per milligram of protein in cell extract. Each value represents the mean ± standard error of the mean of at least three independent experiments.

  • 1-c  Efficiency of MMR displayed by the cell line in two independent experiments.

  • 1-d  Drug concentration required to inhibit cell growth by 50%. Each value represents the mean ± standard error of the mean of at least three independent experiments.

  • 1-e  LTE/BG was performed by incubating cells with 5 μM BG for 2 h before treatment with TMZ or BCNU and maintaining the inhibitor in culture up to the end of the assay.

  • 1-160P < 0.01,

  • 1-150P< 0.05 according to Student's t test comparing for each cell line the IC50 values obtained in the presence of BG with those obtained without the inhibitor.